Media & Advertising
Valeant Pharmaceuticals International (VRX) Is Losing Ground On Offering News
Have an interest in this Story?
Sign Up for Real-Time email updates
June 17, 2013
Valeant Pharmaceuticals International (VRX: Quote) announced a public offering of its common shares to raise gross proceeds of approximately $1.75 billion after the close Monday. The stock is now down 0.82 on 16K shares.Valeant Pharmaceuticals traded in a range for the majority of Monday's session a...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Securities industry Articles
Valeant, Ackman make $45.6B Allergan bid
- Investor's Business Daily
Luoxis Awarded Health Canada Approval for RedoxSYS? Diagnostic System
- Pharmacy Choice
Genworth Financial, Inc announces filing of prospectus for australian initial public
Revised timetable for Meltwater's cash offer of...
Ness Technologies Cited as a Strong Product Development Services Performer by Independent
Corporate Marketing Manager
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.